Silver Oak Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Silver Oak Securities's BMY Position: Q2 2026 in Review
Silver Oak Securities increased its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, buying an estimated $8.67K and bringing the position to 9,134 shares worth $526K. The position accounts for 0.03% of the portfolio, ranked #454.
Silver Oak Securities first reported a position in BMY in Q3 2024 and has held it in 8 quarters since. The position peaked at $545K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Silver Oak Securities held 9,134 shares of Bristol-Myers Squibb worth $526K as of Q2 2026.
- Silver Oak Securities bought 151 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.67K.
- Bristol-Myers Squibb made up 0.03% of Silver Oak Securities's portfolio in Q2 2026, its #454 holding.
- Silver Oak Securities first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 8 quarters since.
- Silver Oak Securities's Bristol-Myers Squibb position peaked at $545K in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Silver Oak Securities's 13F filing for Q2 2026, filed 7 Aug 2026.